- $4.70bn
- $4.26bn
- $401.20m
- 89
- 15
- 92
- 72
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 44.69 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 14 | ||
| Price to Tang. Book | 15.89 | ||
| Price to Free Cashflow | 38.69 | ||
| Price to Sales | 11.72 | ||
| EV to EBITDA | 63.04 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 14.4% | ||
| Return on Equity | -152.88% | ||
| Operating Margin | 14.18% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 194.91 | 246.25 | 270.65 | 325.11 | 401.2 | 484.17 | 569.42 | 18.48% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +43.93 | n/a | n/a | n/a | +17.79 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cellebrite DI Ltd is an Israel-based company engaged primarily in the software sector. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Company provides solutions for the public and private sectors, enabling organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. The Company's platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. The Company aims to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 13th, 1999
- Public Since
- August 31st, 2021
- No. of Shareholders
- 23
- No. of Employees
- 1,167
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
NASDAQ Global Select Market- Shares in Issue
- 239,470,062
- Address
- 94 Shlomo Shmelzer Rd., P.O.B 3925, PETAH TIKVA, 4970602
- Web
- https://www.cellebrite.com
- Phone
- +972 39260900
- Contact
- Andrew Kramer
- Auditors
- Kost, Forer, Gabbay & Kasierer
Upcoming Events for CLBT
Q1 2025 Cellebrite DI Ltd Earnings Release
Cellebrite DI Ltd at Oppenheimer Israeli Conference
Cellebrite DI Ltd at Craig-Hallum Institutional Investor Conference
Cellebrite DI Ltd at TD Cowen Technology, Media & Telecom Conference
Cellebrite DI Ltd at Bank of America Global Technology Conference
Cellebrite DI Ltd at William Blair Growth Stock Conference
Cellebrite DI Ltd at DA Davidson Consumer & Technology Conference
Q2 2025 Cellebrite DI Ltd Earnings Release
FAQ
What is the Cellebrite DI share price?
As of Today at 19:50 UTC, shares in Cellebrite DI are trading at $19.64. This share price information is delayed by 15 minutes.
How has the Cellebrite DI share price performed this year?
Shares in Cellebrite DI last closed at $19.64 and the price had moved by +83.38% over the past 365 days. In terms of relative price strength the Cellebrite DI share price has outperformed the S&P500 Index by +69.27% over the past year.
What are the analyst and broker recommendations for Cellebrite DI?
The overall consensus recommendation for Cellebrite DI is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Cellebrite DI dividend yield?
Cellebrite DI does not currently pay a dividend.
Does Cellebrite DI pay a dividend?
Cellebrite DI does not currently pay a dividend.
When does Cellebrite DI next pay dividends?
Cellebrite DI does not currently pay a dividend.
How do I buy Cellebrite DI shares?
To buy shares in Cellebrite DI you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Cellebrite DI?
As of the previous close price of $19.64, shares in Cellebrite DI had a market capitalisation of $4.70bn.
Where are Cellebrite DI shares listed?
Here are the trading details for Cellebrite DI:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: CLBT
What kind of share is Cellebrite DI?
Based on an overall assessment of its quality, value and momentum Cellebrite DI is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Cellebrite DI share price forecast for 2025?
The analyst consensus target price for shares in Cellebrite DI is $27.33. That is 39.15% above the last closing price of $19.64.
Analysts covering Cellebrite DI currently have a consensus Earnings Per Share (EPS) forecast of $0.42 for the next financial year.
Find out moreWhat is the trend in the Cellebrite DI share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cellebrite DI. Over the past six months, its share price has outperformed the S&P500 Index by +13.18%.
As of the last closing price of $19.64, shares in Cellebrite DI were trading +5.84% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Cellebrite DI PE Ratio?
The Cellebrite DI PE ratio based on its reported earnings over the past 12 months is 44.69. The shares last closed at $19.64.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Cellebrite DI?
Cellebrite DI's management team is headed by:
- Yossi Carmil - CEO
- Dana Gerner - CFO
- Miri Goldenberg - EVP
- Ori Nurick - EVP
- Mark Gambill - CMO